Clearsight and Investec Advise Doceree on Capital Raise

Clearsight Advisors, Inc. (“Clearsight”) is pleased to announce a cross-border transaction in its Healthcare & Life Sciences practice. Investec plc, in partnership with Clearsight, advised Doceree, Inc. (“Doceree” or the “Company”) on a capital raise led by Creaegis Advisors, LLP (“Creaegis”). Existing investors, Eight Roads Ventures, and F-Prime Capital, also participated in the Series B transaction.

Doceree is a leading global network of physician-only platforms for programmatic messaging. Founded in 2019 and headquartered in Parsippany, NJ, the Company empowers pharmaceutical and life sciences companies and healthcare media agencies to achieve better patient health outcomes with solutions that reach healthcare professionals on their networks and within their digital workflows. Creaegis is a digital and technology private equity firm based in India, with previous investments in global SaaS companies and the healthcare ecosystem. This funding will enable Doceree to accelerate product development, augment technologies, scale global expansion, and expand their team.

Clearsight Director Tory Steel commented on the transaction, “With the help of Creaegis, Doceree will accelerate its product and technology development efforts to continue to provide actionable solutions to clients. We congratulate them on this new partnership.”